Pneumotox Online
v2.2
  • RSS Feed
  • Contact
  • News
  • Diagnosing DIRD
  • Browse
  • Available on AppStore Available on AppStore

The Drug-Induced Respiratory Disease Website

Philippe Camus, M.D.

Dijon, France

  • Home
  • Browse by »
  • Drugs
  • Patterns

Gemcitabine

5

III.a Alveolar hemorrhage (AH), diffuse AH (DAH)

1
Last update : 11/05/2012
 
Search
Advanced search
Identify causative drugs
Diagnosing DIRD
1
Drug and radiation history
2
Drug singularity - Correct identification of the drug
3
Consistent timing of exposure v. onset of symptoms
4
Clinical, imaging, BAL, pathological pattern consistent with the specific drug
5
Careful exlusion of another cause
6
Remission of symptoms with removal of drug
7
Recurrence with rechallenge (rarely advisable)
8
Causality assessment
More detailed checklist

Publications

Aetiologies and outcomes of diffuse alveolar haemorrhage presenting as acute respiratory failure of uncertain cause.
Respirology (Carlton, Vic.) 2009 Mar;14;290-4 2009 Mar
[A case of non-small cell lung cancer accompanied with hemorrhage after chemotherapy including gemcitabine].
Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 2006 Mar;44;215-9 2006 Mar
Gemcitabine-associated diffuse alveolar hemorrhage.
Intensive care medicine 2001 Sep;27;1554 2001 Sep
Fatal pulmonary toxicity resulting from treatment with gemcitabine.
Cancer 1997 Jul 15;80;286-91 1997 Jul 15

Powered by

  • ^
  • Contact
  • Cookies
  • About

The Pneumotox website uses cookies. By accessing or using our website, you consent to the collection, use and disclosure of the garnered information in accordance with our privacy policy.

Learn more about cookies